Literature DB >> 34061564

Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer.

Paula Aristizabal1,2, Lena E Winestone3,4, Puja Umaretiya5,6,7,8, Kira Bona6,7,8.   

Abstract

Adult cancer disparities have been documented for decades and continue to persist despite clinical advancements in cancer prevention, detection, and treatment. Pediatric cancer survival has improved significantly in the United States for the past 5 decades to over 80%; however, disparate outcomes among children and adolescents with cancer still affect many populations in the United States and globally, including racial and ethnic minorities, populations with low socioeconomic status, and residents of underserved areas. To achieve equitable outcomes for all children and adolescents with cancer, it is imperative that concerted multilevel approaches be carried out to understand and address health disparities and to ensure access to high-quality cancer care. Addressing social determinants of health, such as removing barriers to health care access and ensuring access to social supports, can reduce pediatric cancer disparities. Nevertheless, public health policy, health system interventions, and innovative delivery of evidence-based services are critically needed. Partnerships among patients, caregivers, and health care providers, and among health care, academic, and governmental institutions, have a pivotal role in reducing cancer disparities and improving outcomes in the 21st century.

Entities:  

Mesh:

Year:  2021        PMID: 34061564      PMCID: PMC9126642          DOI: 10.1200/EDBK_320499

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  83 in total

1.  An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016.

Authors:  Michael E Scheurer; Philip J Lupo; Joachim Schüz; Logan G Spector; Joseph L Wiemels; Richard Aplenc; M Monica Gramatges; Joshua D Schiffman; Maria S Pombo-de-Oliveira; Jun J Yang; Julia E Heck; Catherine Metayer; Manuela A Orjuela-Grimm; Kira Bona; Paula Aristizabal; Mary T Austin; Karen R Rabin; Heidi V Russell; David G Poplack
Journal:  Pediatr Hematol Oncol       Date:  2018-05-08       Impact factor: 1.969

2.  Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010).

Authors:  Kira Bona; Traci M Blonquist; Donna S Neuberg; Lewis B Silverman; Joanne Wolfe
Journal:  Pediatr Blood Cancer       Date:  2016-02-23       Impact factor: 3.167

3.  Pharmacogenetic association with neurotoxicity in Hispanic children with acute lymphoblastic leukaemia.

Authors:  Claire A McClain; M Brooke Bernhardt; Amanda Berger; Juan C Bernini; Deborah Marquez-Do; Ryan Winslow; Michael E Scheurer; Eric S Schafer
Journal:  Br J Haematol       Date:  2017-04-17       Impact factor: 6.998

4.  Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.

Authors:  Paula Aristizabal; Jenelle Singer; Renee Cooper; Kristen J Wells; Jesse Nodora; Mehrzad Milburn; Sheila Gahagan; Deborah E Schiff; Maria E Martinez
Journal:  Pediatr Blood Cancer       Date:  2015-03-08       Impact factor: 3.167

5.  Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

Authors:  B H Pollock; M R DeBaun; B M Camitta; J J Shuster; Y Ravindranath; D J Pullen; V J Land; D H Mahoney; S J Lauer; S B Murphy
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

Review 6.  Expansion of cancer care and control in countries of low and middle income: a call to action.

Authors:  Paul Farmer; Julio Frenk; Felicia M Knaul; Lawrence N Shulman; George Alleyne; Lance Armstrong; Rifat Atun; Douglas Blayney; Lincoln Chen; Richard Feachem; Mary Gospodarowicz; Julie Gralow; Sanjay Gupta; Ana Langer; Julian Lob-Levyt; Claire Neal; Anthony Mbewu; Dina Mired; Peter Piot; K Srinath Reddy; Jeffrey D Sachs; Mahmoud Sarhan; John R Seffrin
Journal:  Lancet       Date:  2010-08-13       Impact factor: 79.321

Review 7.  Overcoming Barriers to Clinical Trial Enrollment.

Authors:  Ryan D Nipp; Kessely Hong; Electra D Paskett
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

8.  Results of therapy for acute lymphoblastic leukemia in black and white children.

Authors:  Ching-Hon Pui; John T Sandlund; Deqing Pei; Gaston K Rivera; Scott C Howard; Raul C Ribeiro; Jeffrey E Rubnitz; Bassem I Razzouk; Melissa M Hudson; Cheng Cheng; Susana C Raimondi; Frederick G Behm; James R Downing; Mary V Relling; William E Evans
Journal:  JAMA       Date:  2003-10-15       Impact factor: 56.272

9.  Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma.

Authors:  Monika L Metzger; Sharon M Castellino; Melissa M Hudson; Shesh N Rai; Sue C Kaste; Matthew J Krasin; Larry E Kun; Ching-Hon Pui; Scott C Howard
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

10.  Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005.

Authors:  Kelsey A Johnson; Richard Aplenc; Rochelle Bagatell
Journal:  Pediatr Blood Cancer       Date:  2011-03       Impact factor: 3.167

View more
  1 in total

1.  Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States.

Authors:  Melissa Beauchemin; Sheila Judge Santacroce; Kira Bona; Ha Dang; Sarah Alexander; Kamala Allen; Crystal De Los Santos; Beth Fisher; Yudy Muñeton-Castaño; Olivia Ponce; Sarah Vargas; Aaron Sugalski; Lillian Sung; Susan Parsons
Journal:  BMC Health Serv Res       Date:  2022-06-28       Impact factor: 2.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.